Form 483

Coapt LLC Form 483, 2014-11-14

FDA issued a Form 483 to Coapt LLC on 2014-11-14 with 8 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health8 observations

Coapt LLC · Chicago, United States · Issued November 14, 2014

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Nov 2014
21 CFR 803.17

Lack of Written MDR Procedures

Cited by That Q Dang, Samuel W Labinjo

14 Nov 2014
21 CFR 820.20(a)

Quality policy and objectives

Cited by That Q Dang, Samuel W Labinjo

14 Nov 2014
21 CFR 820.20(b)

Lack of or inadequate organizational structure

Cited by That Q Dang, Samuel W Labinjo

14 Nov 2014
21 CFR 820.20(d)

Quality plan

Cited by That Q Dang, Samuel W Labinjo

14 Nov 2014
21 CFR 820.20(e)

Quality System Procedures

Cited by That Q Dang, Samuel W Labinjo

Inspected site

CLCoapt LLCChicago, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.17Cited across public-safe Form 483 observations1x
21 CFR 820.181Cited across public-safe Form 483 observations1x
21 CFR 820.20(a)Cited across public-safe Form 483 observations1x
21 CFR 820.20(b)Cited across public-safe Form 483 observations1x
21 CFR 820.20(d)Cited across public-safe Form 483 observations1x
21 CFR 820.20(e)Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.80(e)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere